These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 24982766)
1. Radioembolization of hepatic tumors. Kennedy A J Gastrointest Oncol; 2014 Jun; 5(3):178-89. PubMed ID: 24982766 [TBL] [Abstract][Full Text] [Related]
2. Radioembolization for the Treatment of Primary and Metastatic Liver Cancers. Lee EJ; Chung HW; Jo JH; So Y Nucl Med Mol Imaging; 2019 Dec; 53(6):367-373. PubMed ID: 31867071 [TBL] [Abstract][Full Text] [Related]
3. Role of yttrium-90 in the management of unresectable hepatocellular carcinoma and hepatic metastases. Kousik V; Promila P; Verma R; Gupta A Indian J Gastroenterol; 2016 May; 35(3):179-85. PubMed ID: 27185180 [TBL] [Abstract][Full Text] [Related]
4. Updated survival outcomes and analysis of long-term survivors from the MORE study on safety and efficacy of radioembolization in patients with unresectable colorectal cancer liver metastases. Kennedy A; Cohn M; Coldwell DM; Drooz A; Ehrenwald E; Kaiser A; Nutting CW; Rose SC; Wang EA; Savin MA J Gastrointest Oncol; 2017 Aug; 8(4):614-624. PubMed ID: 28890810 [TBL] [Abstract][Full Text] [Related]
5. Baseline hemoglobin and liver function predict tolerability and overall survival of patients receiving radioembolization for chemotherapy-refractory metastatic colorectal cancer. Kennedy AS; Ball D; Cohen SJ; Cohn M; Coldwell DM; Drooz A; Ehrenwald E; Kanani S; Moeslein FM; Nutting CW; Putnam SG; Rose SC; Savin M; Schirm S; Sharma NK; Wang E J Gastrointest Oncol; 2017 Feb; 8(1):70-80. PubMed ID: 28280611 [TBL] [Abstract][Full Text] [Related]
6. Yttrium-90 Hepatic Radioembolization for Advanced Chemorefractory Metastatic Colorectal Cancer: Survival Outcomes Based on Right- Versus Left-Sided Primary Tumor Location. Wu V; Li MD; Goodwin JS; Wehrenberg-Klee EP; Zurkiya O; Kalva SP; Ganguli S AJR Am J Roentgenol; 2021 Nov; 217(5):1141-1152. PubMed ID: 33594907 [No Abstract] [Full Text] [Related]
7. State of the art: radiolabeled microspheres treatment for liver malignancies. Deleporte A; Flamen P; Hendlisz A Expert Opin Pharmacother; 2010 Mar; 11(4):579-86. PubMed ID: 20163269 [TBL] [Abstract][Full Text] [Related]
9. Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumors. Kuei A; Saab S; Cho SK; Kee ST; Lee EW World J Gastroenterol; 2015 Jul; 21(27):8271-83. PubMed ID: 26217079 [TBL] [Abstract][Full Text] [Related]
10. 90Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study. Hickey R; Lewandowski RJ; Prudhomme T; Ehrenwald E; Baigorri B; Critchfield J; Kallini J; Gabr A; Gorodetski B; Geschwind JF; Abbott A; Shridhar R; White SB; Rilling WS; Boyer B; Kauffman S; Kwan S; Padia SA; Gates VL; Mulcahy M; Kircher S; Nimeiri H; Benson AB; Salem R J Nucl Med; 2016 May; 57(5):665-71. PubMed ID: 26635340 [TBL] [Abstract][Full Text] [Related]
11. Radioembolization of liver tumors with yttrium-90 microspheres. Ahmadzadehfar H; Biersack HJ; Ezziddin S Semin Nucl Med; 2010 Mar; 40(2):105-21. PubMed ID: 20113679 [TBL] [Abstract][Full Text] [Related]
12. Radioembolization with Fidelman N; Kerlan RK; Hawkins RA; Pampaloni M; Taylor AG; Kohi MP; Kolli KP; Atreya CE; Bergsland EK; Kelley RK; Ko AH; Korn WM; Van Loon K; McWhirter RM; Luan J; Johanson C; Venook AP J Gastrointest Oncol; 2016 Dec; 7(6):860-874. PubMed ID: 28078110 [TBL] [Abstract][Full Text] [Related]
13. Radioembolization (yttrium-90 microspheres) for primary and metastatic hepatic malignancies. Kennedy AS; Salem R Cancer J; 2010; 16(2):163-75. PubMed ID: 20404614 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization. Schmeel FC; Simon B; Luetkens JA; Träber F; Meyer C; Schmeel LC; Sabet A; Ezziddin S; Schild HH; Hadizadeh DR J Cancer Res Clin Oncol; 2017 Aug; 143(8):1531-1541. PubMed ID: 28317063 [TBL] [Abstract][Full Text] [Related]
17. Radiation oncology approaches in liver malignancies. Kennedy AS Am Soc Clin Oncol Educ Book; 2014; ():e150-5. PubMed ID: 24857096 [TBL] [Abstract][Full Text] [Related]
18. Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres. Wang EA; Stein JP; Bellavia RJ; Broadwell SR Int J Clin Pract; 2017 Nov; 71(11):. PubMed ID: 28758319 [TBL] [Abstract][Full Text] [Related]
19. Radioembolization in the treatment of unresectable liver tumors: experience across a range of primary cancers. Coldwell D; Sangro B; Salem R; Wasan H; Kennedy A Am J Clin Oncol; 2012 Apr; 35(2):167-77. PubMed ID: 21127414 [TBL] [Abstract][Full Text] [Related]
20. Internal radiation therapy for patients with primary or metastatic hepatic cancer: a review. Ho S; Lau WY; Leung TW; Johnson PJ Cancer; 1998 Nov; 83(9):1894-907. PubMed ID: 9806647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]